Castlefield Stock Story - CVS Group
In this month's Stock Story, Investment Analyst David Gorman introduces a relatively recent addition to our TM Castlefield Thoughtful UK Smaller Companies Fund, CVS Group. Based in Norfolk, CVS is a leading provider of veterinary services in Britain and Australia.

The company operates veterinary practices for companion animals (pets), horses and farm animals; specialist referral hospitals and out-of-hours emergency veterinary services. Alongside its Veterinary Practices, CVS also runs three laboratories (providing diagnostic services), a buying group for practitioners (VetDirect), a pet health plan (The Healthy Pet Club) and an online retail business called Animed Direct.[1]
CVS has grown steadily through the acquisition and subsequent consolidation of independent veterinary clinics across the country. The company now has around 500 practices across Britain and Australia, including nine specialist-led referral hospitals, 40 dedicated out-of-hours sites, 22 equine and fifteen farm practices. Some CVS sites feature multiple veterinary practices, such as a small animal practice alongside an equine practice.
CVS benefits from positive long-term trends such as increasing pet ownership levels, rising demand for animal healthcare services, the growth of pet insurance and the increasing humanisation of companion animals.
As a business, CVS benefits from positive long-term trends such as increasing pet ownership levels, rising demand for animal healthcare services, the growth of pet insurance and the increasing humanisation of companion animals, all of which drive demand for more premium products and services. The UK and Australian veterinary service markets are growing rapidly[2][3] and there is scope for further consolidation within both markets.
For vets looking to sell an established practice, selling to CVS offers a good exit. After possibly decades of building up a practice, with all the stress and long hours that come with it, a group like CVS can offer an attractive upfront lump sum to sellers that individual buyers, usually other vets, can’t match. Beyond the financial incentives, selling allows senior vets to pass on the heavy administrative, financial, and regulatory pressures of modern practice ownership, such as HR, payroll, tax, rising overheads and strict compliance rules. Joining CVS also gives practices access to centralized resources, diagnostic labs, out-of-hours cover and relief staff, helping practicing vets focus on their clinical work.
CVS Group buys existing veterinary practices to secure immediate revenue, trained staff and a loyal base of pet owners without the high risks of building a new clinic from scratch.
So, what’s in it for CVS? CVS Group buys existing veterinary practices to secure immediate revenue, trained staff and a loyal base of pet owners without the high risks of building a new clinic from scratch. Buying established surgeries provides instant cash flow and helps the company build local networks that can share staff, specialist equipment and out-of-hours services. Adding more clinics increases CVS's buying power for wholesale supplies, avoids duplicating back-office costs like payroll and HR and feeds steady referrals directly into its own diagnostic laboratories, crematoria and online pharmacy.

From a sustainability standpoint, CVS Group delivers societal benefits through its commitment to animal welfare, providing veterinary care and support across the entire lifespan of both companion and production animals. The company also contributes to human wellbeing, as the illness of a pet can be highly stressful for owners and access to quality veterinary care can alleviate this burden. Also, by diagnosing, treating and preventing diseases in animals, CVS plays an important role in reducing the risk of zoonotic disease transmission and protecting public health.
The CVS board is aware of the emotionally demanding nature of the job for vets, nurses and staff. If unmanaged, poor wellbeing leads to reduced productivity, absenteeism and can negatively affect patient care and client satisfaction. CVS practitioners are given the freedom to make the best decisions for patients and for their own careers. A network of Pastoral Support Vets, mentors and Wellbeing Champions help CVS staff to look after their career and mental health.
To customers, pricing and trust are important and some owners might be feeling vulnerable due to their relationships with their pets. Concerns over pricing and billing transparency in the sector attracted the attention of the Competition and Markets Authority (CMA) which, in 2023, launched an investigation into the industry. This process concluded earlier this year by mandating greater transparency in pricing but it is not forcing groups like CVS to break up or sell practices. Under the final order, CVS and other large corporate groups must implement major changes by December 2026, i.e. next month.
Changes include clearly showing corporate ownership on clinic signage and websites. Practices are also required to publish price lists, provide written estimates for expensive treatments and supply itemised bills. To prevent big markups on animal medication, the CMA has capped written prescription fees and requires clinics to inform pet owners that they can buy medicines cheaper elsewhere.
CVS Group welcomed the outcome of the CMA investigation, expressing relief over the regulatory certainty after more than two years of scrutiny and uncertainty.
CVS Group welcomed the outcome of the CMA investigation, expressing relief over the regulatory certainty after more than two years of scrutiny and uncertainty. Since the CMA stopped short of forcing clinic divestments or banning future buyouts, CVS immediately moved to resume UK acquisitions after pausing while the investigation unfolded.
With the CMA investigation over and its recommendations now seen as business as usual, we look forward to CVS making good progress in the years ahead.
Written by David Gorman
Information is correct as at 13.11.2026. Opinions constitute the fund manager’s judgement as of this date and are subject to change without warning. The officers, employees and agents of CIP may have positions in any securities mentioned herein. This material may not be distributed, published or reproduced in whole or in part. With investment, capital is at risk.